Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models

• Lindsay Riley,

  Affiliation Department of Biomathematics, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Hua Zhou,

  Affiliation Department of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America

  ⨯
• Kenneth Lange,

  Affiliations Department of Biomathematics, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Human Genetics, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Statistics, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Janet S. Sinsheimer,

  Affiliations Department of Biomathematics, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Human Genetics, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biostatistics, School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Mary E Sehl

  * E-mail: msehl@mednet.ucla.edu

  Affiliation Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯